Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | KLK7 | P49862 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14982726 | 1.00 | KDM4E (0.64) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL16756631 | 1.00 | KDM4E (0.64) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL31084773 | 1.00 | KDM4E (0.64) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL13988760 | 1.00 | KDM4E (0.64) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL29441870 | 1.00 | KDM4E (0.64) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL2945952 | 0.96 | KDM4E (0.65) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL2945957 | 0.96 | KDM4E (0.65) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL15619957 | 0.94 | KDM4E (0.57) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL2954322 | 0.94 | KDM4E (0.57) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL21594318 | 0.94 | KDM4E (0.57) | KDM4EATML3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11152577-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-19 | — | — | US | disclosed |
| US-20200251665-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2020-08-06 | — | — | US | disclosed |
| US-10672991-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-02 | — | — | US | disclosed |
| US-10367155-B2 | Organometallic complex and organic light-emitting diode including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-10326085-B2 | — | — | 2019-06-18 | — | — | US | disclosed |
| US-10170706-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-01 | — | — | US | disclosed |
| US-9997728-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-12 | — | — | US | disclosed |
| EP-2762546-B1 | Organic electroluminescent element, and display and illuminator | KONICA MINOLTA HOLDINGS INC (JP) | 2018-06-06 | — | — | EP | disclosed |
| EP-2765174-B1 | Organic electroluminescent element, and display and illuminator | KONICA MINOLTA HOLDINGS INC (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-9929358-B2 | Organic light-emitting devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-9799839-B2 | Organometallic compound and organic light-emitting diode comprising the same | Samsung Diplay Co., Ltd. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-20170244050-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-24 | — | — | US | disclosed |
| US-20170244050-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-24 | — | — | US | disclosed |
| US-9595683-B2 | Organometallic compounds and organic light emitting devices including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-14 | — | — | US | disclosed |
| US-7795801-B2 | Organic electroluminescent element, illuminator, display and compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7795801-B2 | Organic electroluminescent element, illuminator, display and compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7629060-B2 | Liquid crystal cells; durability, stability; brightness ; containing carbazole compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-7629060-B2 | Liquid crystal cells; durability, stability; brightness ; containing carbazole compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-12-08 | — | — | US | disclosed |
| EP-1641894-B1 | NOVEL MATERIALS FOR ELECTROLUMINESCENCE | MERCK PATENT GMBH (DE) | 2009-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10367155-B2 | Organometallic complex and organic light-emitting diode including the same | MT-CO1, CRY1, MDH2 | KDM4E 3188/4885ATM 1925/4885L3MBTL1 279/4885 |
| US-10326085-B2 | — | CRY1, CRY2, SOD1 | KDM4E 3632/4885ATM 2071/4885L3MBTL1 280/4885 |
| US-10170706-B2 | Amine-based compound and organic light-emitting device including the same | TYR, DOT1L, CRY1 | KDM4E 466/4885ATM 543/4885L3MBTL1 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.